Works matching IS 1933088X AND DT 2025 AND VI 24 AND IP 1

Results: 80

Rapid Transition From Oral Selexipag to Intravenous Treprostinil in a Patient With Severe Pulmonary Arterial Hypertension.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 102, doi. 10.21693/1933-088X-24.1.102

By:

Jain, Ruchi P.;
Bo Tang;
Satya, Kumar

Publication type:

Article

Roundtable Discussion: Highlights From the Seventh World Symposium on Pulmonary Hypertension.

Published in:: Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 25, doi. 10.21693/1933-088X-24.1.25
Publication type:: Article

Getting Started Early in Your Pulmonary Hypertension Career.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 23, doi. 10.21693/1933-088X-24.1.23

By:

DesJardin, Jacqueline T.;
Minhas, Jasleen;
Singh, Navneet;
De Marco, Teresa

Publication type:

Article

Defining Disease Modification in Pulmonary Arterial Hypertension.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 16, doi. 10.21693/1933-088X-24.1.16

By:

Habib, Naomi;
Sahay, Sandeep

Publication type:

Article

Pulmonary Hypertension Associated With Parenchymal Lung Disease.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 9, doi. 10.21693/1933-088X-24.1.9

By:

Ogunnaike, Rahila;
Matusov, Yuri

Publication type:

Article

A Roundtable Discussion Addressing Patient-Centered Care and Quality of Life in Patients With Pulmonary Arterial Hypertension.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 5, doi. 10.21693/1933-088x-24.1.5

By:

Stiyer, Tina;
Visovatti, Scott H.

Publication type:

Article

Editor's Memo.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 4, doi. 10.21693/1933-088x-24.1.4

By:

Krasuski, Richard A.

Publication type:

Article

Guest Editor's Memo.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 3, doi. 10.21693/1933-088x-24.1.3

By:

Hopper, Rachel K.

Publication type:

Article

THE DEVELOPMENT OF A MULTIDISCIPLINARY PULMONARY HYPERTENSION CLINIC AT A COMMUNITY HEALTH SYSTEM.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 101, doi. 10.21693/1933-088X-24.1.29

By:

Castle, L.;
Gorbett, D.;
Dickson, M.;
Alspach, E.;
Vacha, B.;
Grisafo, T.;
Brooks, K.;
Ohl, M.

Publication type:

Article

TRANSITIONING BETWEEN TREPROSTINIL FORMULATIONS: EVIDENCE AND STRATEGIES.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 95, doi. 10.21693/1933-088X-24.1.29

By:

Clarke, M. M.;
Miller, C. E.;
Turkin, A.;
Kantorovich, A.

Publication type:

Article

UNDER PRESSURE: A CASE OF PROGRESSIVE PERICARDIAL EFFUSION IN A PULMONARY HYPERTENSION PATIENT.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 99, doi. 10.21693/1933-088X-24.1.29

By:

Bennett, K.;
Castle, L.;
Gorbett Jr., D.;
Enlow, J.

Publication type:

Article

TRPV4 CONTRIBUTES TO ANGIOTENSIN II-INDUCED RIGHT VENTRICULAR HYPERCONTRACTILITY IN ISOLATED HEARTS OF TYPE 3 PULMONARY HYPERTENSIVE MICE.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 98, doi. 10.21693/1933-088X-24.1.29

By:

Behrmann, A.;
Nourian, Z.;
Norton III, C. E.;
Domeier, T. L.

Publication type:

Article

TRIAL IN PROGRESS: PROSERA, A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF SERALUTINIB IN ADULTS WITH PULMONARY ARTERIAL HYPERTENSION.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 97, doi. 10.21693/1933-088X-24.1.29

By:

Johri, S.;
Benza, R. L.;
Channick, R. N.;
Chin, K. M.;
Frantz, R. P.;
Ghofrani, H.-A.;
Hemnes, A. R.;
Howard, L. S.;
Sitbon, O.;
Vachiéry, J.-L.;
Zamanian, R. T.;
Bruey, J.-M.;
Cravets, M.;
Mottola, D.;
Zisman, L. S.;
Parsley, E.;
Roscigno, R. F.;
Aranda, R.;
McLaughlin, V. V.

Publication type:

Article

TREPROSTINIL PALMITIL HYDROLYSIS IS FACILITATED BY ENDOGENOUS LUNG ENZYMES.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 96, doi. 10.21693/1933-088X-24.1.29

By:

Nguyen, T.;
Chang, C.;
Li, Z.;
Malinin, V. S.;
Perkins, W. R.;
Viramontes, V.;
Zhou, J.;
Corboz, M. R.

Publication type:

Article

UNMASKING LEFT VENTRICULAR DIASTOLIC DYSFUNCTION: IMPLICATIONS OF GROUP 1 PULMONARY HYPERTENSION TREATMENT.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 100, doi. 10.21693/1933-088X-24.1.29

By:

Desai, K. V.;
Alsheimer, K. M.;
Hehn, B. T.;
Yang, H.

Publication type:

Article

THE ASCENT STUDY: AN OPEN-LABEL PROSPECTIVE MULTICENTER STUDY TO EVALUATE SAFETY AND TOLERABILITY OF DRY-POWDER INHALED TREPROSTINIL IN PULMONARY HYPERTENSION.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 93, doi. 10.21693/1933-088X-24.1.29

By:

Patel, S.

Publication type:

Article

TBX4 SYNDROME: A PARADIGM OF HERITABLE PULMONARY ARTERIAL HYPERTENSION AFFECTING PEDIATRIC AND ADULT POPULATIONS.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 93, doi. 10.21693/1933-088X-24.1.29

By:

Austin, E.

Publication type:

Article

SINGLE CENTER EXPERIENCE WITH THE USE OF AMBRISENTAN IN PEDIATRIC PATIENTS LESS THAN 2 YEARS OF AGE.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 92, doi. 10.21693/1933-088X-24.1.29

By:

Cosnahan, A.;
O'Neill, S. R.;
Montgomery, G. S.;
Johansen, M. W.

Publication type:

Article

SCARRED PHOR LIFE: TIP OF THE ICEBERG.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 91, doi. 10.21693/1933-088X-24.1.29

By:

Crosswhite, B. D.;
Dang, T.;
Balasubramanian, V.

Publication type:

Article

SAFETY AND TOLERABILITY OF LIQ861 (YUTREPIA™ IN PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE INSPIRE STUDY.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 91, doi. 10.21693/1933-088X-24.1.29

By:

Patel, S.

Publication type:

Article

RISK ASSESSMENT IN PULMONARY ARTERIAL HYPERTENSION: INSIGHTS FROM THE INSPIRE STUDY WITH LIQ861 (YUTREPIATM).

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 90, doi. 10.21693/1933-088X-24.1.29

By:

Patel, S.

Publication type:

Article

RIGHT HEART CATHETERIZATION PRACTICE PATTERNS IN PULMONARY HYPERTENSION DIAGNOSIS IN THE UNITED STATES: A CROSS-SECTIONAL ANALYSIS.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 87, doi. 10.21693/1933-088X-24.1.29

By:

Soto, F. J.;
Shlobin, O.;
Levine, D.;
Sahay, S.;
Bhagat, M.;
Sood, N.;
Balasubramanian, V.;
Farmer, M. J.;
Bernardo, R.;
Vintch, J.;
Pandit, L.;
Pettigrew, S.;
Elwing, J.

Publication type:

Article

REAL-WORLD SAFETY AND EFFICACY OF RIOCIGUAT IN ADULTS WITH PULMONARY ARTERIAL HYPERTENSION: 6-MONTH DATA FROM THE RIOCIGUAT USERS (ROAR) REGISTRY.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 86, doi. 10.21693/1933-088X-24.1.29

By:

Chakinala, M. M.;
Aranda, A. U.;
Mandras, S.;
McConnell, J. W.;
Miller, C. E.;
Papamatheakis, D. G.;
Kim, N. H.;
Sulica, R.;
White, R. J.;
Yaghmour, B.;
Carvajal, V.;
Poon, V.;
Hegab, S.

Publication type:

Article

REAL-WORLD DISCONTINUATION RATE OF INHALED TREPROSTINIL IN PATIENTS WITH PULMONARY HYPERTENSION IN INTERSTITIAL LUNG DISEASE.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 85, doi. 10.21693/1933-088X-24.1.29

By:

Robinson, K.;
Thomas, A.;
Hall, H.;
Ball, K.;
Fineberg, S.;
Hawkins, C.;
Schriver, E.;
Biney, I.;
Kravitz, J.;
Soto, F. J.

Publication type:

Article

QUALITY OF LIFE IN PULMONARY ARTERIAL HYPERTENSION PATIENTS RECEIVING AN INHALED DRY-POWDER TREPROSTINIL (LIQ861) IN THE INSPIRE STUDY.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 85, doi. 10.21693/1933-088X-24.1.29

By:

Patel, S.

Publication type:

Article

PULMONARY HYPERTENSION IS ASSOCIATED WITH MORBIDITY, MORTALITY AND PROLONGED HOSPITALIZATION IN PREMATURE INFANTS WITH BRONCHOPULMONARY DYSPLASIA.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 84, doi. 10.21693/1933-088X-24.1.29

By:

Bjorkman, K. R.;
Becker, K.;
Ta, H. T.;
Schneider, K.;
Bellew, L.;
Hysinger, E.;
Magness, M.;
Critser, P. J.

Publication type:

Article

PULMONARY HYPERTENSION ASSOCIATION REGISTRY: A STATUS UPDATE AND RESOURCE FOR RESEARCH.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 82, doi. 10.21693/1933-088X-24.1.29

By:

Burger, C.;
Williams, K. M.;
Blank, K. N.;
Drager, Z. M.;
Joseloff, E. G.

Publication type:

Article

PRIOR AUTHORIZATIONS FOR PEDIATRIC PULMONARY HYPERTENSION MEDICATIONS.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 80, doi. 10.21693/1933-088X-24.1.29

By:

Yung, D.;
Merrill, K. M.;
Davis, A.;
Jackson, E. O.;
Riker, M.

Publication type:

Article

PRIOR AUTHORIZATION RESTRICTIVENESS NEGATIVELY AFFECTS TIME TO RECEIPT OF ENDOTHELIN RECEPTOR ANTAGONIST THERAPY FOR PULMONARY ARTERIAL HYPERTENSION.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 80, doi. 10.21693/1933-088X-24.1.29

By:

Chakinala, M. M.

Publication type:

Article

PRELIMINARY LONG-TERM DATA FROM ADVANCE EXTENSION, A PHASE 3, OPEN-LABEL STUDY EVALUATING RALINEPAG FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 79, doi. 10.21693/1933-088X-24.1.29

By:

Barberà, J. A.;
Amuchastegui, M.;
Ataya, A.;
Bohns Meyer, G. M.;
Feenstra, J.;
Jerjes-Sanchez Diaz, C.;
Kaminski, K.;
Vasilyeva, L. I.;
Cella, D.;
Escudero, M.;
Grover, R.;
Solum, D.;
Lachant, D.

Publication type:

Article

PRACTICAL MANAGEMENT OF ORAL TREPROSTINIL AND ADVERSE EFFECTS: LESSONS FROM THE ADAPT REGISTRY AND EXPERT CONSENSUS.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 77, doi. 10.21693/1933-088X-24.1.29

By:

Brewer, J.;
La Roy, V.;
Wilson, M.;
Coons, J.;
Schmit, A.;
Kimber, A.;
Broderick, M.;
Lee, D.;
Patzlaff, N.;
Ataya, A.

Publication type:

Article

PORTOPULMONARY HYPERTENSION COMPLICATED BY LIVER CANCER: JOURNEY TO A SUCCESSFUL LIVER TRANSPLANT.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 76, doi. 10.21693/1933-088X-24.1.29

By:

Saini, I.;
Hage, A.

Publication type:

Article

PLATELET-DERIVED GROWTH FACTOR-BB ANTAGONIST MONOCLONAL ANTIBODY AS A THERAPY FOR PULMONARY ARTERIAL HYPERTENSION.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 75, doi. 10.21693/1933-088X-24.1.29

By:

Gao, Y.;
Sundaram, B.;
Del Priore, I.;
Kaplan, T.;
Liu, C.;
Ruan, Q.;
Megna, J.;
Jin, X.;
Zhang, D.;
Torello, J.;
Cheng, L.;
Chalothorn, D.;
Ehrlich, G.;
Rafique, A.;
Kim, J. H.;
Ho, A.;
Lee, J.;
Garnova, E.;
Foster, R.;
Weisbarth, T.

Publication type:

Article

PULMONARY HYPERTENSION ASSOCIATION REGISTRY CARE STANDARDS FOR PARTICIPATING PATIENTS WITH WORLD HEALTH ORGANIZATION GROUP 1 PULMONARY ARTERIAL HYPERTENSION POSITIVELY INFLUENCE CARE PROVIDED TO COMPARABLE PATIENTS NOT ENROLLED IN THE REGISTRY.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 74, doi. 10.21693/1933-088X-24.1.29

By:

Swisher, J.;
Jorgensen, P.;
Huckaby, M.

Publication type:

Article

PERCEPTIONS OF THE PROSTACYCLIN PATHWAY: INSIGHTS FROM A PULMONARY ARTERIAL HYPERTENSION PATIENT ENGAGEMENT RESEARCH COUNCIL.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 74, doi. 10.21693/1933-088X-24.1.29

By:

Han, M.;
Massaad, R.;
Doad, G.

Publication type:

Article

PATTERNS AND OUTCOMES OF EPOPROSTENOL USE IN INFANTS WITH CONGENITAL DIAPHRAGMATIC HERNIA REQUIRING EXTRACORPOREAL LIFE SUPPORT.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 73, doi. 10.21693/1933-088X-24.1.29

By:

Burgi, K.;
Shah, N. R.;
Lotakis, D. M.;
Perrone, E. E.;
Church, J.;
Michalski, G. B.;
Olive, M. K.;
McCormick, A.

Publication type:

Article

PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASSOCIATED PULMONARY HYPERTENSION DEMONSTRATE REDUCTION IN EXERTIONAL VENTRICULAR-ARTERIAL COUPLING: A PILOT STUDY USING INVASIVE CARDIOPULMONARY EXERCISE TESTING.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 71, doi. 10.21693/1933-088X-24.1.29

By:

Forbes, L. M.;
Hunter, K.;
Nathe, K.;
Kreye, S.;
Bull, T. M.;
Cornwell, W. K.;
Make, B. J.;
Lahm, T.

Publication type:

Article

PATIENT PREFERENCES REGARDING THE USE OF COMBINATION ERA+PDE5I FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM A DISCRETE CHOICE EXPERIMENT.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 70, doi. 10.21693/1933-088X-24.1.29

By:

Wilson, M.;
Kingman, M.;
Kolaitis, N. A.;
Melendres-Groves, L.;
Rendon, G. G.;
Paoli, C. J.;
Lopez, D.;
Rahman, M.;
Martin, A.;
Mirza, S.;
McGarvey, N.;
Lee, A.

Publication type:

Article

PULMONARY ARTERIAL HYPERTENSION 1-YEAR SURVIVAL PREDICTION USING INTEGRATIVE NONINVASIVE LAB AND MAGNETIC RESONANCE IMAGING VARIABLES.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 69, doi. 10.21693/1933-088X-24.1.29

By:

Cartwright, M.;
Lin, S.;
Correa-Jaque, P.;
Vanderpool, R.;
Fauvel, C.;
Kanwar, M.;
Kraisangka, J.;
Perer, A.;
Everett, A.;
Alabed, S.;
Swift, A.;
Kiely, D.;
Benza, R.

Publication type:

Article

NEW CANDIDATE GENES IMPLICATED IN THE DEVELOPMENT OF PULMONARY ARTERIAL HYPERTENSION.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 68, doi. 10.21693/1933-088X-24.1.29

By:

Tenorio, J.

Publication type:

Article

MANAGING PATIENT EXPECTATIONS WHEN TREATED WITH ORAL SELEXIPAG FOR PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM A DELPHI CONSENSUS SURVEY.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 67, doi. 10.21693/1933-088X-24.1.29

By:

Wu, S.;
Doad, G.;
Benninger, C.;
Cho, M.;
Strachan, P.;
Perry, R.;
Bridge, D.;
Oswald, C.;
Val-Maranes, L.

Publication type:

Article

MAKING A SPLASH... IN SEARCH OF A SAFE WAY TO SUBMERGE ON SUBCUTANEOUS TREPROSTINIL THERAPY.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 66, doi. 10.21693/1933-088X-24.1.29

By:

Kittel, D.

Publication type:

Article

INTERIM RESULTS FROM THE PHASE 1B AND PHASE 2 TORREY OPEN-LABEL EXTENSION STUDY OF SERALUTINIB IN PULMONARY ARTERIAL HYPERTENSION.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 65, doi. 10.21693/1933-088X-24.1.29

By:

Channick, R. N.;
Zolty, R. L.;
Kingrey, J. F.;
Penn, B.;
Sobol, I.;
Sood, N.;
Benza, R. L.;
Frantz, R. P.;
Ghofrani, H.-A.;
Hemnes, A. R.;
Howard, L. S.;
McLaughlin, V.;
Sitbon, O.;
Vachiéry, J.-L.;
Zamanian, R. T.;
Cravets, M.;
Roscigno, R. F.;
Mottola, D.;
Parsley, E.;
Aranda, R.

Publication type:

Article

INCREMENTAL BURDEN OF PULMONARY HYPERTENSION AMONG PATIENTS WITH CONNECTIVE TISSUE DISEASE-RELATED INTERSTITIAL LUNG DISEASE IN THE REAL-WORLD SETTING.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 63, doi. 10.21693/1933-088X-24.1.29

By:

Burger, C.;
Wu, J.;
Wieman, M.;
Ismat, F.;
Shah, B.;
O'Brien, G.;
Ward, T.;
Shamsunder, M.

Publication type:

Article

IN VIVO MODELING OF ARTERIOVENOUS MALFORMATIONS AND HEREDITARY HEMORRHAGIC TELANGIECTASIA MIMICRY DUE TO PROSPECTIVE PULMONARY ARTERIAL HYPERTENSION THERAPIES.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 63, doi. 10.21693/1933-088X-24.1.29

By:

Yu, P.;
Zeghibe, A.;
Rajesh, S.

Publication type:

Article

IMPROVED OUTCOMES WITH EARLY INITIATION OF COMBINATION TRIPLE THERAPY IN NEWLY DIAGNOSED INTERMEDIATE TO HIGH-RISK PULMONARY ARTERIAL HYPERTENSION.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 62, doi. 10.21693/1933-088X-24.1.29

By:

Guglielmi, A.;
Hristakos, N.;
Nowrozi, A.;
Ndiaye, M.;
LaRoy, V.;
Victor, N.;
Pauwaa, S.;
Macaluso, G. P.;
Dia, M.

Publication type:

Article

IMPLEMENTATION OF A DIGITAL PEER MENTOR SUPPORT PILOT PROJECT FOR PULMONARY HYPERTENSION PATIENTS.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 60, doi. 10.21693/1933-088X-24.1.29

By:

McDevitt, S.;
Burks, M.;
Cascino, T.;
Moles, V.;
McLaughlin, V.;
Hoffman, P.

Publication type:

Article

IDENTIFICATION OF KEY GENETIC FACTORS ASSOCIATED WITH HYPERTENSIVE HEART DISEASE IN AFRICAN AMERICANS IN THE UNITED STATES.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 58, doi. 10.21693/1933-088X-24.1.29

By:

Chakafan, G.

Publication type:

Article

HIGH-RESOLUTION COMPUTED TOMOGRAPHY CHEST SCANS TO EXAMINE THE ASSOCIATION BETWEEN REGIONAL DRUG DEPOSITION OF LIQ861 (YUTREPIA™) AND VASODILATION IN PULMONARY HYPERTENSION IN INTERSTITIAL LUNG DISEASE POPULATION.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 58, doi. 10.21693/1933-088X-24.1.29

By:

Patel, S.

Publication type:

Article

HANK THE HEART GETS FOCUSED ON PHIGHTING PULMONARY HYPERTENSION.

Published in:

Advances in Pulmonary Hypertension, 2025, v. 24, n. 1, p. 57, doi. 10.21693/1933-088X-24.1.29

By:

Cash, M.;
Magness, M.;
Luebbe, K.;
Critser, P.

Publication type:

Article